Development Services
Bora Biologics understands the complexities of bringing biologics to market. Our expertise in Analytical Development (AD), Formulation Development (FD), Mammalian Process Development, and Microbial Process Development, combined with cutting-edge technologies, ensures your project is in capable hands, from concept to First-in-Human (FIH) studies. Our tailored solutions ensure compliance, enhance product quality, and accelerate your time to market.
• Analytical Development and Validation
• Bioassays and Potency Testing
• Process Development (PD)
• Manufacturing Science and Technology (MSAT)
• Stability Studies
• Characterization of Biologics
Have a question? Tell us what you need and one of our experienced colleagues will connect.


Why Choose Bora Biologics?
With a track record of successful development projects, Bora Biologics has established itself as a reliable partner in the biopharmaceutical industry. Our collaborations with leading companies highlight our commitment to and excellence in biologics development.
- Comprehensive Expertise
- Proven Track Record
- Mammalian and Microbial Expertise
- Regulatory Compliance
- Reliable Method Validation
- Innovative Formulation Solutions
- Tailored Delivery Systems
Comprehensive Expertise
Our team excels in developing robust assays tailored to your specific biologics, ensuring accurate measurement of potency and purity. We utilize advanced chromatography techniques and mass spectrometry for detailed characterization, providing the insights necessary for informed decision-making.
Proven Track Record
With over 45 biologics and biosimilars developed, over 100 successful cGMP batches delivered, a commercially approved biosimilar in the U.S. and Canada, and partnerships with leading pharmaceutical and biotech companies, we have established ourselves as a trusted partner in the biologics industry.
Mammalian and Microbial Expertise
We specialize in a diverse range of biologics, including fusion proteins, monoclonal antibodies, antibody derivatives, bispecific and trispecific antibodies, antibody-drug conjugates (ADCs), enzymes, and other innovative biologics. Our extensive experience in both mammalian and microbial systems enables us to deliver high-quality solutions tailored to your specific needs.
Regulatory Compliance
Our FDA-registered facility in the U.S. and our membership in PIC/S, ensure that we adhere to the highest global standards for drug substance production. This positions us to deliver quality biologics for clinical trials worldwide.
Reliable Method Validation5>
We employ industry-standard protocols for method validation, guaranteeing reproducibility and compliance with regulatory requirements. Consistency across production batches is achieved through stringent quality control measures and real-time analytics during production.
Innovative Formulation Solutions
Developing stable and effective formulations is our priority. We conduct rigorous stability studies in climate-controlled chambers and leverage formulation software for predictive modeling to enhance solubility and prevent aggregation, ensuring optimal performance in clinical settings.
Tailored Delivery Systems
We design and optimize delivery systems that safeguard product integrity. We also utilize automated liquid handling systems to improve efficiency and accuracy in our processes.

Thought Leadership
Working with Bora Biologics to develop our recombinant protein has been an excellent experience. Bora’s team has been fully engaged during the cell line and scale-up process and responsive to Technical and Quality requests. We hope to continue working with them to manufacture.
CEO of Q-Sera


Integrated Allosteric Formulation Development Platform
Our cutting-edge Allosteric Formulation Development Platform enables fast, economical, and precise formulation development for a variety of biologics, including:
- Monoclonal antibodies and their fragments
- Antibody-Drug Conjugates (ADCs)
- Cytokines, enzymes, and growth factors
- Synthetic peptides and recombinant fusion proteins
- Liposomes, lipid nanoparticles (LNPs), micelles, and polymers
Biophysical and Analytical Platforms
We employ advanced biophysical and analytical techniques to ensure comprehensive characterization of drug products:
- Biophysical High Throughput Platform
- Spectroscopy Techniques: Fluorescence, CD, NMR, ESR, FTIR, Raman, and Light Scattering (LS)
- Biophysical Techniques: Differential Scanning Calorimetry (DSC), Analytical Ultracentrifugation (AUC), and Surface Plasmon Resonance (SPR)
- Analytical Platform
- A variety of HPLC-based methods (e.g., SEC, RP, CEX, HIC, HILIC), MALS, cIEF, CE-SDS, and mass spectrometry (MS)
- Comprehensive assessments of osmolality, particle size (HIAC), morphological characterization (MFI), photostability, pH, viscosity, and protein concentration/solubility (A280/350)
- Design of Experiments (DOE) and statistical analysis using JMP and GraphPad

Bora Biologics
the logical choice
Join the ranks of biopharma pioneers who trust us.
Explore how we minimize risks and accelerate your success.
Client-Centric
100% commitment to supporting your success
Experience
14 years developing & manufacturing biologics
Expertise
125 seasoned scientists & regulatory professionals
Commercial-Ready
US FDA registered GMP manufacturing facility
Allied
access to global CDMO resources